Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Supplement

  • You have access
    Dosimetry for Radiopharmaceutical Therapy: The European Perspective
    Michael Lassmann, Uta Eberlein, Jonathan Gear, Mark Konijnenberg and Jolanta Kunikowska
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 73S-79S; DOI: https://doi.org/10.2967/jnumed.121.262754
  • You have access
    Artificial Intelligence in Nuclear Medicine
    Felix Nensa, Aydin Demircioglu and Christoph Rischpler
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 29S-37S; DOI: https://doi.org/10.2967/jnumed.118.220590
  • You have access
    The Future of Nuclear Medicine as an Independent Specialty
    Johannes Czernin, Ida Sonni, Aria Razmaria and Jeremie Calais
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 3S-12S; DOI: https://doi.org/10.2967/jnumed.118.220558
  • You have access
    Nuclear Medicine and Wall Street: An Evolving Relationship
    Mike Sherman and Rachel Levine
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 20S-24S; DOI: https://doi.org/10.2967/jnumed.118.220798
  • You have access
    Radiomics: Data Are Also Images
    Mathieu Hatt, Catherine Cheze Le Rest, Florent Tixier, Bogdan Badic, Ulrike Schick and Dimitris Visvikis
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 38S-44S; DOI: https://doi.org/10.2967/jnumed.118.220582
  • You have access
    Driving the Future of Nuclear Medicine
    Ken Herrmann, Patrick Veit-Haibach and Wolfgang A. Weber
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.119.232264
  • You have access
    Do You Want an Inspirational Career? Choose Nuclear Medicine
    Steven M. Larson
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 25S-28S; DOI: https://doi.org/10.2967/jnumed.118.220574
  • You have access
    Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
    Thomas Langbein, Wolfgang A. Weber and Matthias Eiber
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.118.220566
  • You have access
    Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
    Rachel Levine and Eric P. Krenning
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
  • You have access
    Somatostatin Receptor 2–Targeting Compounds
    Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire